On January 6, 2022, Anderson, Kenneth C.; Hideshima, Teru; Dhe-Paganon, Sirano; Seo, Hyuk-Soo; Mizutani, Takashi; Zhang, Tinghu published a patent.Category: piperidines The title of the patent was PRPK inhibitors. And the patent contained the following:
This disclosure relates to compounds of formula (I) as defined in the Specification. This disclosure also relates to methods of synthesizing the compound of formula I and using the compounds of formula I for treating a disease (e.g., cancer). The experimental process involved the reaction of 2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid(cas: 1216805-11-6).Category: piperidines
The Article related to prpk inhibitor cancer, Pharmaceuticals: Formulation and Compounding and other aspects.Category: piperidines
Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem